Ionis Pharmaceuticals Inc (NASDAQ:IONS)

44.85
Delayed Data
As of May 25
 -0.38 / -0.84%
Today’s Change
39.07
Today|||52-Week Range
65.51
-10.83%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Crooke Stanley T
Chairman & Chief Executive Officer
Sale1/03/201820,000$50.02$1.0M-10.34%
Crooke Stanley T
Chairman & Chief Executive Officer
Sale10/13/201715,000$59.46$891.9K-24.11%
Crooke Stanley T
Chairman & Chief Executive Officer
Sale1/15/201815,893$51.76$822.6K-12.14%
Bennett C Frank
Senior Vice President-Antisense Research
Sale10/18/201712,250$65.00$796.3K-29.80%
Crooke Stanley T
Chairman & Chief Executive Officer
Sale7/17/201715,000$52.45$786.8K-15.39%
Crooke Stanley T
Chairman & Chief Executive Officer
Sale7/03/201713,462$52.08$701.1K-14.11%
Bennett C Frank
Senior Vice President-Antisense Research
Sale2/01/201812,500$52.50$656.3K-14.88%
Bennett C Frank
Senior Vice President-Antisense Research
Sale7/24/201710,000$59.29$592.9K-24.70%
Muto Frederick T
Director
Sale5/31/201712,500$45.22$565.3K-2.05%
Bennett C Frank
Senior Vice President-Antisense Research
Sale5/11/201812,500$45.00$562.5K-2.39%
Page of 18